Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Tiffany P. Quock"'
Publikováno v:
Blood Advances, Vol 2, Iss 10, Pp 1046-1053 (2018)
Abstract: Amyloid light-chain (AL) amyloidosis is a rare disease caused by extracellular deposition of misfolded immunoglobulin light chains. This study aimed to provide an up-to-date estimate of prevalence and incidence of AL amyloidosis in the Unit
Externí odkaz:
https://doaj.org/article/19bebe0d4fd144d7a600e783c6da03d9
Autor:
Avery A Rizio, Michelle K White, Anita D’Souza, Kristen Hsu, Paula Schmitt, Tiffany P Quock, James Signorovitch, Isabelle Lousada, Vaishali Sanchorawala
Publikováno v:
Patient Related Outcome Measures. 14:153-169
Autor:
Morie A. Gertz, Rafat Abonour, Sarah N. Gibbs, Muriel Finkel, Heather Landau, Suzanne Lentzsch, Grace Lin, Anuj Mahindra, Tiffany P. Quock, Cara A. Rosenbaum, Michael Rosenzweig, Surbhi Sidana, Sascha A. Tuchman, Ronald Witteles, Irina Yermilov, Michael S. Broder
Publikováno v:
Blood. 140:13129-13131
Publikováno v:
Patient Related Outcome Measures
Avery A Rizio,1 Kristen L McCausland,1 Michelle K White,1 Tiffany P Quock2 1QualityMetric Incorporated, LLC, Johnston, RI, USA; 2Prothena Biosciences Inc, South San Francisco, CA, USACorrespondence: Avery A RizioQualityMetric Incorporated, LLC, 1301
Autor:
Tiffany P Quock, Anita D'Souza, Michael S Broder, Katalin Bognar, Eunice Chang, Marian H Tarbox
Publikováno v:
Journal of comparative effectiveness research.
Aim: Describe the clinical and economic burden of hospitalizations for amyloid light chain (AL) amyloidosis. Materials & methods: This retrospective analysis used nationally representative hospital discharge data (2017–2020) to report discharge sta
Autor:
Anita D’Souza, Michael S Broder, Katalin Bognar, Eunice Chang, Marian H Tarbox, Tiffany P Quock
Publikováno v:
Journal of comparative effectiveness research. 11(17)
Aim: Estimate the frequency and costs of diagnostic admissions among hospitalized patients with amyloid light chain (AL) amyloidosis. Materials & methods: This retrospective analysis used nationally representative hospital discharge data from 2017 to
Publikováno v:
Patient Related Outcome Measures. 11:149-160
Purpose Amyloid transthyretin (ATTR) amyloidosis is a rare, progressive, and fatal disease. The ATTR Patient Symptom Survey (ATTR-PSS) was previously developed through literature review and concept elicitation input from clinicians and patients and r
Publikováno v:
ClinicoEconomics and Outcomes Research. 11:431-439
Purpose Cardiac dysfunction is common in amyloid light-chain (AL) amyloidosis, a rare disease caused by extracellular deposition of misfolded immunoglobulin light chains. This study aimed to examine economic/clinical disease burden in hospitalized ca
Autor:
Avery A. Rizio, Kristen L. McCausland, Martha S. Bayliss, Michelle K. White, Tiffany P. Quock
Publikováno v:
PharmacoEconomics Open
Introduction Light-chain (AL) amyloidosis is a rare, progressive, and typically fatal disease. Health-related quality of life (HRQoL) has been shown to be a significant prognostic factor associated with clinical outcomes such as survival and response
Autor:
Spencer D. Guthrie, Kristen L. McCausland, Avery A. Rizio, Tiffany P. Quock, Martha S. Bayliss, Michelle K. White, Vaishali Sanchorawala
Publikováno v:
British Journal of Haematology. 185:998-1001